Your browser doesn't support javascript.
loading
Ginsenoside Rg1 provides neuroprotection against blood brain barrier disruption and neurological injury in a rat model of cerebral ischemia/reperfusion through downregulation of aquaporin 4 expression.
Zhou, Yun; Li, Hui-qin; Lu, Lin; Fu, Deng-lei; Liu, Ai-ju; Li, Ji-huang; Zheng, Guo-qing.
Afiliação
  • Zhou Y; The Center of Neurology and Rehabilitation, The Second Affiliated Hospital of Wenzhou Medical University, Wenzhou 325027, China.
  • Li HQ; The Center of Neurology and Rehabilitation, The Second Affiliated Hospital of Wenzhou Medical University, Wenzhou 325027, China.
  • Lu L; The Center of Neurology and Rehabilitation, The Second Affiliated Hospital of Wenzhou Medical University, Wenzhou 325027, China.
  • Fu DL; The Center of Neurology and Rehabilitation, The Second Affiliated Hospital of Wenzhou Medical University, Wenzhou 325027, China.
  • Liu AJ; The Center of Neurology and Rehabilitation, The Second Affiliated Hospital of Wenzhou Medical University, Wenzhou 325027, China.
  • Li JH; The Center of Neurology and Rehabilitation, The Second Affiliated Hospital of Wenzhou Medical University, Wenzhou 325027, China.
  • Zheng GQ; The Center of Neurology and Rehabilitation, The Second Affiliated Hospital of Wenzhou Medical University, Wenzhou 325027, China. Electronic address: gq_zheng@sohu.com.
Phytomedicine ; 21(7): 998-1003, 2014 Jun 15.
Article em En | MEDLINE | ID: mdl-24462216

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Barreira Hematoencefálica / Traumatismo por Reperfusão / Isquemia Encefálica / Fármacos Neuroprotetores / Ginsenosídeos Tipo de estudo: Prognostic_studies Limite: Animals Idioma: En Ano de publicação: 2014 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Barreira Hematoencefálica / Traumatismo por Reperfusão / Isquemia Encefálica / Fármacos Neuroprotetores / Ginsenosídeos Tipo de estudo: Prognostic_studies Limite: Animals Idioma: En Ano de publicação: 2014 Tipo de documento: Article